Pharma Solutions
Overview
Cardio Metabolic
MASLD/MASH
Autoimmune Disease
Gastrointestinal Disease
Oncology
Clinical Solutions
LiverMultiScan
MRCP+
CoverScan
Hepatica
Perspectum Portal
Research
Overview
Publications
Research Projects
Research Network
company
Overview
Senior Management
Board of Directors
Company News
Careers
Events
Webinars
Media Center
OUR LOCATIONS
< RETURN TO RESEARCHERS
Publications
Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Filter by disease type
Any
Filter by product
Any
Search:
placeholder
clear filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Quantitative multiparametric MRI allows safe surgical planning in patients undergoing liver resection for colorectal liver metastases: report of two patients
Author:
Pulkit Sethi, Navamayooran Thavanesan, Fenella KS Welsh, Damian J Mole, Jonathan A Fallowfield, John J Connell, Elisabeth Pickles, Matt Kelly, Myrddin Rees
Journal:
BJR | case reports
Publication Year:
2021
Volume/Issue:
6
Pages:
20200172
Hepatic steatosis rather than underlying obesity increases risk of infection and hospitalization for COVID-19
Author:
Adriana Roca-Fernandez, Andrea Dennis, Rowan Nicholls, John McGonigle, Matthew Kelly, Rajarshi Banerjee and Arun Sanyal
Journal:
Frontiers in Medicine Gastroenterology
Publication Year:
2021
Volume/Issue:
8
Pages:
636637
Prospective evaluation of the prevalence of nonalcoholic fatty liver disease and steatohepatitis in a large middle-aged United States cohort
Author:
Stephen A. Harrison, Samer Gawrieh, Katharine Roberts, Christopher J. Lisanti, Ryan B. Schwope, Katherine M. Cebe, Valerie Paradis, Pierre Bedossa, Jennifer M. Aldridge Whitehead, Aymeric Labourdette, Véronique Miette, Stefan Neubauer, Céline Fourn
Journal:
Journal of Hepatology
Publication Year:
2021
Volume/Issue:
S0168-8278(21)
Pages:
00176-8
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Author:
Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson D, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A
Journal:
BMJ Open
Publication Year:
2021
Volume/Issue:
11(3)
Pages:
e048391
1
...
22 / 27
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD